Mavacamten will lower the extent or effect of ethinylestradiol by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Progestin and ethinyl estradiol are CYP3A4 substrates. Mavacamten may perhaps lower systemic exposures of ethinyl estradiol and progestin, which may produce contraceptive failure or an increase in breakthrough bleeding. Amongst https://zanderrpmhl.onesmablog.com/a-secret-weapon-for-wymzya-fe-birth-control-70752024